Glioblastoma is the most aggressive brain tumor, and its prognosis remains poor. Therefore, novel therapeutic strategies are needed for glioma therapy. Polyphyllin I (PPI), a bioactive constituent extracted from Paris polyphylla, was reported to have anti-tumor activity. However, the detailed mechanism for this activity remains unclear. Here, we investigated the inhibitory effects of PPI on glioma cells and its mechanisms in vitro. U251 cells were treated with various concentrations of PPI (2-9 μM) for 24 to 72 h. The inhibition of U251 cell proliferation by PPI was assessed by MTT assay. The effects on cell cycle and apoptosis were examined by flow cytometry with PI and annexin V-FITC/PI dual staining, and the cell mitochondrial membrane potential level was evaluated by fluorescence microscopy with JC-1 staining. The expression levels of apoptosis-related proteins and JNK signal pathway proteins were evaluated by western blot analysis. Results showed that PPI significantly inhibited the proliferation of U251 cells in a concentration-dependent manner. PPI induced G 2 /M phase arrest and apoptosis, and it upregulated the expressions of Bax, cytochrome c, and p-JNK, but downregulated the expression of the anti-apoptotic protein Bcl-2 in U251 cells. Moreover, PPI provoked the depolarization of the mitochondrial membrane potential. In addition, apoptosis induced by the PPI was remarkably suppressed by the JNK inhibitor SP600125. Our data provide evidence that PPI inhibits proliferation and induces apoptotic cell death in U251 cells. This effect may be associated with the JNK pathway. These results suggest that PPI is an activator of the JNK signaling pathway with a potential anti-glioma effect.
Introduction
Glioblastoma is the most aggressive cerebral glioma and the most common and highly invasive tumor, comprising approximately 50%-60% of cerebral gliomas [1, 2] . Currently, surgical intervention with a combination of surgery, chemotherapy, and radiotherapy is still the major treatment strategy for gliomas. However, the median survival duration of patients with glioblastoma remains~1 year [3, 4] . Despite recent advances in all of these therapies, they continue to be very poor [5] . Therefore, novel therapeutic strategies are required. There is an urgent need to search for new agents with minimal side effects and improved treatment efficacy. Some components from Chinese medical herbs have the characteristic of being anti-tumor, and among these, polyphyllin I (PPI) may be one of such candidates.
PPI, a steroidal saponin, is one of the main bioactive components of Rhizoma of Paris polyphyllin (Fig. 1A) , and it has a wide range of medicinal activities, including anti-cancer, immune-regulatory, and cardiovascular effects. PPI also known as Chong-Lou in China, has been widely prescribed by herbal doctors to treat many types of tumors including breast cancer [6] , gastric cancer [7] , ovarian cancer [8] , lung cancer [9] , glioblastoma, myeloma [10] , and hepatocellular cancer [11] . PPI can inhibit tumor cell growth by influencing many pathways, such as cell cycle arrest [12] and mitochondrial dysfunction-mediated apoptosis [13, 14] . Nevertheless, whether PPI can inhibit the growth and proliferation of glioma cells remains to be investigated. Moreover, the detailed mechanism underlying its effects on glioma cells remains largely unknown.
Previous studies have demonstrated that apoptosis can be induced by diverse apoptosis stimuli on mitochondria, causing mitochondrial dysfunction, cytochrome c (cyto c) release, Bax activation, and eventually apoptotic cell death [15] . Dysregulation of the cell cycle and cell proliferation causes unrestrained cell growth and cancer development [16] . The G 2 checkpoint allows the cell to repair DNA damage before entering mitosis. Numerous signaling pathways play a vital role in the process of apoptosis. The mitogenactivated protein kinases (MAPKs), a family of serine/threonine kinases, have been reported to play an important role in the nervous system [17, 18] . The c-Jun N-terminal kinase (JNK) pathway is one of the MAPK pathways, and its activation could promote glioma cell apoptosis [19, 20] . Thus, we have focused on effects of the JNK pathway in PPI-treated glioma cells in our studies.
In this study, the inhibitory effects of PPI on the growth in U251 human glioma cells, as well as its molecular mechanisms were examined. Our results showed that PPI inhibits the cell viability of U251 cells and induces the apoptotic cell death. Results also showed that the JNK inhibitor SP6000125 inhibits the increased apoptosis and the levels of related proteins induced by PPI in U251 cells. These results implied that PPI strongly inhibits the proliferation of U251 cells by arresting the cell cycle at the G 2 /M phase and induces apoptosis and mitochondrial dysfunction through the activation of the JNK signaling pathway. Moreover, it was also found that PPI has the inhibitory effect on other glioma cell lines U87, which suggested that PPI has characteristic of generality in glioma cells. Taken together, these data suggest that PPI is a natural compound with anti-proliferative and pro-apoptotic effects for glioma treatment.
Materials and Methods

Materials
PPI was purchased from Langchem Pharmaceutical Technology (Shanghai, China), with a purity of >98%. The propidium iodide (PI) kit and SP600125 were purchased from Sigma-Aldrich (St. Louis, USA). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) kit, annexin V-FITC apoptosis detection kit and mitochondrial membrane potential (ΔΨm) kit were purchased from Beyotime Institute of Biotechnology (Shanghai, China). DMEM medium and fetal bovine serum (FBS) were purchased from Hyclone (Los Angeles, USA). Antibodies specific to Bcl-2, Bax, cyt c, cyt c oxidase subunit IV (COX IV), p-JNK, and t-JNK were purchased from Santa Cruz Biotechnology (Santa Cruz, USA) or Proteintech Group Inc. (Wuhan, China). Antibodies specific to 24, 48 , and 72 h, and the cell inhibitory ratio was detected by the MTT assay. ***P < 0.001, **P < 0.01, and *P < 0.05, versus control.
β-actin and all secondary antibodies were purchased from Santa Cruz Biotechnology. The enhanced chemiluminescence (ECL) detection kit was obtained from Millipore (Billerica, USA).
Cell culture and treatments
The human glioma cell lines U251 and U87 were purchased from the Kunming Institute of Zoology, Chinese Academy of Sciences (Kunming, China). Cells were cultured in plastic cell culture dishes and maintained in low-glucose DMEM with 10% FBS. Normal human astrocytes were obtained from ScienCell and cultured in specific astrocyte medium (ScienCell, Shanghai, China). All cells were incubated in an incubator with 5% CO 2 and 95% humidity at 37°C. After reaching an 80%-90% confluent layer, the cells were used in the experiments described below. PPI was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution, sterilized using a sterile 0.22 μm membrane filter and stored at −80°C.
Cell viability assay
Cell growth was measured by MTT assay. Cells were seeded in 96-well plates at a density of 10,000 cells per well. After 24 h, U251 cells were treated with a vehicle (DMSO) or different concentrations (2, 3, 4, 5, 6, 7, 8, or 9 μM) of PPI for 24, 48, and 72 h. Normal human astrocytes were also treated with a vehicle (DMSO) or different concentrations (2, 3, 4, 5, 6, 7, 8, or 9 μM) of PPI for 48 h. After treatment, the MTT reagents were added to each well and incubated for 4 h. DMSO was added to all wells for 2-3 h and the absorbance of the wells were measured at 570 nm using a microplate spectrophotometer (Molecular Devices Technologies, San Jose, USA). The cell viability was calculated as follows: cell inhibitory ratio = 1−(OD 570 sample−OD 570 blank)/(OD 570 control−OD 570 blank) × 100%. The IC 50 values were calculated using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, USA).
Cell cycle and apoptosis analysis
U251 cells were divided into various groups. After treatment, flow cytometry was used to determine the cell cycle and apoptosis. Briefly, treated cells were fixed in 70% cold ethanol for 2 h, stained with 50 μg/ml PI at 4°C for 30 min and then assessed with a flow cytometer (FACS PARTEC, Münster, Germany). For apoptosis analysis, the cells were harvested with 0.25% trypsin after treatment. The harvested cells were washed with cold PBS and resuspended in 100 μl of binding buffer/well. Then, 5 μl of Annexin V-FITC was added, and the sample was incubated in the dark for 30 min at room temperature. Then, the cells were incubated with 5 μl of PI in the dark and analyzed with a flow cytometer.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was determined by staining with JC-1 (Beyotime, Shanghai, China). Briefly, after the U251 cells were treated with vehicle (DMSO) or 6 μM PPI for 24 and 48 h, the cells were collected. A staining mixture (300 nM JC-1) was prepared according to the manufacturer's instructions enclosed in the JC-1 kit. The cells were incubated with the staining mixture for 30 min at 37°C. Then, the cells were washed twice with media and resuspended in fresh media. The ΔΨm was monitored with a fluorescence microscope (Olympus, Tokyo, Japan).
Isolation of cytosol and mitochondrial fractions
Isolation of cytosol and mitochondrial was performed according to the instructions of the Mitochondria/cytosol isolation kit (Applygen, Beijing, China). Cytosol and mitochondrial proteins were collected, and the concentrations of these proteins were determined using the BCA method.
Western blot analysis
Total proteins, cytosol proteins, and mitochondrial proteins were extracted respectively from U251 cells with various treatments. Western blot analysis was performed to determine the expressions of cyto c, Bcl-2, Bax, p-JNK, and t-JNK. Briefly, U251 cells were washed with cold PBS. The insoluble protein lysate was removed by centrifugation at 24,149 g for 15 min at 4°C. Total proteins and cytosol proteins were separated by 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a PVDF membrane (Millipore, Billerica, USA). After being blocked with 5% skim milk, membranes were incubated overnight with anti-cyto c (1:1000), anti-Bcl-2 (1:1000), anti-Bax (1:1000), anti-p-JNK (1:500), and anti-t-JNK (1:500) antibodies, respectively. Then membranes were hybridized with horseradish peroxidase (HRP) conjugated-secondary antibodies for 2 h at room temperature. The immunopositive bands were developed using an ECL detection system (Thermo, Waltham, USA). Total and cytosol β-actin, and the mitochondrial Cyt c oxidase subunit IV (COX IV) were used as a control. The relative amounts of the various proteins were analyzed. The results were quantified using Image J software.
Statistical analysis
All experiments were performed in triplicate with three independent experiments. The results are expressed as the mean ± SD. Statistical significance was determined with an unpaired Student's t-test and one-way analysis of variance (ANOVA) with Tukey's post hoc test using GraphPad Prism Version 5.0a. P < 0.05 was considered statistically significant.
Results
PPI inhibits the growth of U251 human glioma cells U251 cells were treated with different concentrations (2, 3, 4, 5, 6, 7, 8, or 9 μM) of PPI for 24, 48, and 72 h, and then, the cell inhibitory ratio and IC 50 values were determined by MTT assay. As shown in Fig. 1C , PPI significantly inhibited cell growth in a doseand time-dependent manner, and the IC 50 values of the PPI were 9.104, 5.741, and 5.302 μM at 24, 48, and 72 h, respectively. The time of 48 h is moderate and the IC 50 of PPI in U251 cells at 48 h was 5.741 μM, so 6 μM of PPI was chosen for the subsequent experiments. The effects of PPI on the growth of normal human astrocytes were also detected by MTT assay. Our results showed that PPI has no cytotoxicity in normal human astrocytes (Fig. 1B) . To further identify the generality of PPI in other glioma cell lines, the effects of PPI on the growth of U87 cells were detected by MTT assay. As shown in Fig. 1D , PPI also markedly suppressed the growth of U87 cells in a dose-and time-dependent manner. These data indicated that PPI strongly inhibited the growth of U251 glioma cells and had the characteristic of generality in other glioma cells. Moreover it has no influence in normal human astrocytes.
PPI induces G 2 /M phase arrest in U251 cells
To evaluate the effect of PPI on the cell cycle and proliferation, cell cycle progression was measured by flow cytometry. U251 cells were treated with 6 μM of PPI for 48 h and analyzed for cell cycle characteristics. Results showed that PPI inhibited the growth of U251 cells with morphological change of U251 cells displaying circular and cell shrinkage ( Fig. 2A) . As shown in Fig. 2B ,C, treatment of U251 cells with PPI resulted in an increase of cells in the G 2 /M phase, which was accompanied by a decrease of cells in the G 0 /G 1 phase as compared to control cells. These results demonstrated that PPI could induce G 2 /M phase arrest in U251 glioma cells.
PPI induces U251 cell apoptosis
To examine whether PPI can induce apoptosis in U251 cells, PPItreated cells were analyzed by flow cytometry after double staining with Annexin V-FITC/PI. As shown in Fig. 3A ,B, the apoptotic rate of cells was increased by PPI. The rate of early apoptosis was increased from 0.56% in the control group to 29.15% after treatment with PPI. These results demonstrated that PPI could induce apoptosis in U251 glioma cells.
To evaluate more precisely the role of PPI in the mitochondriadependent apoptotic pathway, anti-apoptotic Bcl-2, pro-apoptotic protein Bax, cytosol, and mitochondrial cyto c were detected by western blot analysis., Results showed that treatment with PPI alone significantly decreased anti-apoptotic Bcl-2 protein expression level, and increased the expression level of the pro-apoptotic protein Bax, and the release of cytochrome c from mitochondria to cytosol in U251 glioma cells (Fig. 3C,D) . These results indicated that PPI could induce apoptosis in U251 glioma cells through mitochondrial apoptosis pathway.
PPI disrupts mitochondrial membrane potential in U251 cells
JC-1 staining was applied to detect changes in the mitochondrial membrane potential level of U251 cells. As shown in Fig. 4A , red fluorescence represents normal mitochondria, whereas green fluorescence represents depolarized mitochondria. The ratios of JC-1 green-to-red fluorescence intensities were significantly increased when U251 cells were treated with PPI for 24 and 48 h (Fig. 4B) . The results revealed that PPI could increase mitochondrial membrane permeability and cause mitochondrial dysfunction of U251 cells, indicating that the induction of apoptosis in U251 cells by PPI was through mitochondrial dysfunction.
PPI induces apoptosis of U251 cells via the JNK pathway
To further examine whether PPI can induce U251 human glioma cell apoptosis via the JNK pathway, t-JNK, p-JNK, Bcl-2, Bax, cytosol, and mitochondrial cyto c protein expression levels were determined by western blot analysis. The JNK inhibitor SP600125 (20 μM) was used to pretreat U251 cells before treatment with PPI. As shown in Fig. 5A ,B, the levels of p-JNK and t-JNK were significantly increased in U251 cells treated with PPI, whereas pretreatment with SP600125 dramatically increased p-JNK expression level. The western blot analysis results revealed a significant upregulation of Bax and cytosol cyto c protein levels and a significant downregulation of Bcl-2 protein and mitochondrial cyto c levels after treatment with PI (Fig. 5A,B) . Interestingly, the treatment with the specific JNK inhibitor SP600125 significantly decreased the protein expressions of Bax and cytosol cyto c, and increased the Bcl-2 and mitochondrial cyto c levels compared with PPI alone. Cytosol β-actin was used as a control for cytosol cyto c protein, total β-actin was used as a control for other proteins, and mitochondrial COX IV was used as a control for mitochondrial cyto c protein. ***P < 0.001, and **P < 0.01, versus control. As shown in Fig. 5C ,D, PPI could markedly induce apoptosis, however, the specific JNK inhibitor SP600125 suppressed the increased apoptosis induced by PPI in U251 cells. These results indicated that PPI might play a role in promoting apoptosis of U251 human glioma cells by increasing the activity of the JNK signaling pathway.
Discussion
Glioma is a highly invasive brain tumor. Epidemiological data show that the survival rate of glioma patients has been very low for decades [21] . The rapid growth ability of glioma cells can help develop resistance to some effective therapies, leading to ineffective treatment [22] . Among the regulators involved in cell death, apoptosis is a major strategy and method for tumor therapy. Because of multi-drug resistance and severe side effects of current chemotherapy for cancers, developing new therapeutic agents for tumors is always in demand.
The mechanisms of action of traditional Chinese medicine on tumor growth mainly through the induction of tumor cell apoptosis. The steroidal saponins isolated from herbs possess significant anticancer functions [23, 24] . P. polyphylla has been used to treat tumors for centuries [25] . PPI is the potential anti-tumor active component in P. polyphylla. However, the cellular and molecular mechanisms for the anti-tumor effects of PPI on gliomas are poorly understood.
Cell cycle arrest and apoptosis are cell defense mechanisms to clear malignant cells, and they play key roles in preventing tumor development. In the present study, we found that PPI could inhibit the growth of U251 cells in a dose-dependent manner, and significantly induced the G 2 /M phase arrest and apoptosis in human glioma U251 cells.
Cell cycle checkpoints play major roles in protecting genomic DNA against environmental agents that may cause DNA damage and chromosome segregation [26, 27] . In this study, we found that PPI increased cell-cycle arrest at the G 2 /M phase and decreased the G 0 /G 1 phase, which may allow cells to complete DNA replication by repairing damaged DNA and therefore suppressing the tumor growth process. Previous studies have shown that PPI can induce cell cycle arrest and apoptosis in human myeloma cells [10] .
Apoptosis is the process of programmed cell death, leading to cellular suicide. Many anti-cancer agents can induce apoptosis. Therefore, analysis of apoptosis induction was performed in U251 human glioma cells treated with PPI. Our results demonstrated that PPI induced apoptosis in U251 cells. Apoptosis can be initiated by various intracellular signals, such as DNA damage, disruption of the mitochondria and regulation of the Bcl-2 protein family [28] . The balance between the anti-apoptotic protein Bcl-2 and the proapoptotic protein Bax is critical for determining whether a cell undergoes apoptosis [29] . Moreover, apoptosis is involved in the release of cytochrome c from the intermembrane space into the cytosol. In this study, by examining the expression levels of Bcl-2, Bax, and cyto c proteins, we found that PPI strongly induced apoptosis in The apoptotic percentage is shown as a bar graph. Cytosol β-actin was used as a control for cytosol cyto c protein, total β-actin was used as a control for other proteins, and mitochondrial COX IV was used as a control for mitochondrial cyto c protein. ***P < 0.001, and **P < 0.01, versus control. U251 cells as evidenced by western blot analysis and Annexin V/PI staining.
Depolarization of the mitochondrial membrane and the subsequent release of mitochondrial pro-apoptotic factors can induce mitochondria-mediated apoptosis [30] . Therefore we analyzed the mitochondrial membrane potential (ΔΨm) by JC-1 assay. JC-1 is a cationic dye that indicates ΔΨm by reversibly shifting its fluorescence emission between green and red. When ΔΨm is high, JC-1 is assembled in the mitochondrial matrix to form J-aggregates which produces red fluorescence. When ΔΨm is lower, JC-1 can not be assembled in the mitochondrial matrix to form J-aggregates. Instead, it forms a monomer, which produces green fluorescence. Our results showed that PPI increased the ratio of the JC-1 green-tored fluorescence intensity, indicating a decrease of ΔΨm and depolarization of the mitochondrial membrane. This further confirmed that PPI induced mitochondrial pathway-mediated apoptosis in U251 cells.
A recent report has shown that JNK is involved in the regulation of cellular pathways such as apoptosis [31] . Some studies have also revealed that JNK may regulate apoptosis through the regulation of Bax and Bcl-2 [32] . To examine whether PPI induces apoptosis through the JNK pathway, the JNK inhibitor SP600125 was used to block JNK in this study. Our results showed that the expression levels of Bax, cytosol cyto c, t-JNK, and p-JNK were all significantly inhibited by SP600125, whereas the expressions of Bcl-2 and mitochondrial cyto c were enhanced. These results indicated that the apoptosis induced by PPI may be associated with the JNK pathway. It has been reported that Polyphyllin D can induce apoptosis in U87 human glioma cells through JNK pathway, but the detailed apoptotic mechanism has not been revealed [33] . In this study, we examined the changes of the mitochondrial membrane potential and the cytosol cytochrome c protein level in PPI-treated U251 cells. Researcher can easily understand the effect of PPI on apoptotic cell death in glioma cells and its related mechanism.
In summary, we demonstrate that PPI can suppress cell growth and induce cell cycle arrest in U251 human glioma cells, thereby promoting cell apoptosis through the activation of the JNK pathway. This provides a novel perspective on the role of PPI in preventing the progression of gliomas.
